Comparative effectiveness research in the Neurosciences

Annals of Neurology

Volumn 65, Issue 2, 2009, Pages

  Johnston, S Claiborne ^a   Hauser, Stephen L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; BETA INTERFERON; DIAZEPAM; GLATIRAMER; INDOMETACIN; METHYLPREDNISOLONE; PHENYTOIN; PLACEBO; PROPRANOLOL; SELEGILINE; TOCOPHEROL; TOPIRAMATE; VALPROIC ACID; WARFARIN;

ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BUDGET; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG MEGADOSE; EDITORIAL; HUMAN; LIFE EXPECTANCY; LOW DRUG DOSE; MEDICARE; MIGRAINE; NEUROSCIENCE; PARKINSON DISEASE; PRIORITY JOURNAL; SEIZURE; SPINAL CORD INJURY; STENT; STROKE;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HEALTH CARE COSTS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; NEUROSCIENCES; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 62549099078     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21682     Document Type: Editorial

References (7)

1. Orszag PR. Research on the Comparative Effectiveness of Medical Treatments: A Congressional Budget Office Paper. Washington: Congress of the United States, 2007.
2. Arias E. United States life tables, 2004. Natl Vital Stat Rep 2007;56:1-39.
3. Murphy KM, Topel RH, eds. Measuring the Gains from Medical Research. Chicago: University of Chicago, 2003.
4. Wilensky GR. Developing a Center for Comparative Effectiveness Information. Health affairs (Project Hope) 2006;25:w572-585.
5. Lyles A. Comparative Effectiveness Research: NICE for the NHS, but False Starts for the US. Clinical Therapeutics 2008;30:1702-1703.
6. Johnston SC. Rootenberg JD, Katrak S, et al. Effect of a US National Institutes of Health Programme of Clinical Trials on Public Health and Costs. Lancet 2006;367:1319-1327.
7. Lohr KN. Emerging Methods in Comparative Effectiveness